amino}benzoic acid, …](https://static.cymitquimica.com/products/3D/img/VCA84448.png "Cliccare per ingrandire")
Methotrexate related compound E (4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
CAS: 70844-48-3
Rif. 3D-VCA84448
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
Methotrexate is a drug that is used to treat autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease. It is also used to treat cancer, including urothelial carcinoma, and some forms of leukemia. Methotrexate inhibits the production of immune cells by binding to folic acid receptors in lymphocytes. Methotrexate-related compound E (MTCE) is a methotrexate analog with immunosuppressive activity. MTCE binds to the folate receptor in a similar manner to methotrexate, but does not inhibit dihydrofolate reductase like methotrexate does. This means that MTCE has lower toxicity than methotrexate because it does not interfere with DNA synthesis or repair as much as methotrexate does.
MTCE has been shown to decrease disease activity in vivo models of autoimmune diseases and bowel disease. The molecule was found to be non-toxic in
Proprietà chimiche
Richiesta tecnica su: 3D-VCA84448 Methotrexate related compound E (4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
